These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 28431920)

  • 1. The microbiome in anti-cancer therapy.
    Bashiardes S; Tuganbaev T; Federici S; Elinav E
    Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
    Pitt JM; Vétizou M; Daillère R; Roberti MP; Yamazaki T; Routy B; Lepage P; Boneca IG; Chamaillard M; Kroemer G; Zitvogel L
    Immunity; 2016 Jun; 44(6):1255-69. PubMed ID: 27332730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the microbiome on cancer progression and response to anti-cancer therapies.
    Buchta Rosean C; Feng TY; Azar FN; Rutkowski MR
    Adv Cancer Res; 2019; 143():255-294. PubMed ID: 31202360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the Microbiome to Enhance Cancer Immunotherapy.
    Nelson MH; Diven MA; Huff LW; Paulos CM
    J Immunol Res; 2015; 2015():368736. PubMed ID: 26101781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
    Dzutsev A; Goldszmid RS; Viaud S; Zitvogel L; Trinchieri G
    Eur J Immunol; 2015 Jan; 45(1):17-31. PubMed ID: 25328099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms.
    Sun L; Chen L; Li H
    Int Immunopharmacol; 2019 Feb; 67():160-175. PubMed ID: 30553199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight into cancer immunotherapy.
    Escribese MM; Barber D
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():50-55. PubMed ID: 29108766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.
    Zitvogel L; Ma Y; Raoult D; Kroemer G; Gajewski TF
    Science; 2018 Mar; 359(6382):1366-1370. PubMed ID: 29567708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy.
    Wan X; Song M; Wang A; Zhao Y; Wei Z; Lu Y
    Front Immunol; 2021; 12():747914. PubMed ID: 34745119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune Cardiotoxicity of Cancer Immunotherapy.
    Cheng F; Loscalzo J
    Trends Immunol; 2017 Feb; 38(2):77-78. PubMed ID: 27919707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adapting Cancer Immunotherapy Models for the Real World.
    Klevorn LE; Teague RM
    Trends Immunol; 2016 Jun; 37(6):354-363. PubMed ID: 27105824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation.
    Yaguchi T; Kawakami Y
    Int Immunol; 2016 Aug; 28(8):393-9. PubMed ID: 27401477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of intestinal microbiota in the response to anti-tumor therapies].
    Vétizou M; Daillère R; Zitvogel L
    Med Sci (Paris); 2016 Nov; 32(11):974-982. PubMed ID: 28008838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy.
    Strouse C; Mangalam A; Zhang J
    Gut Microbes; 2019; 10(2):109-112. PubMed ID: 30183502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the commensal microbiota on distal tumor-promoting inflammation.
    Buchta Rosean CM; Rutkowski MR
    Semin Immunol; 2017 Aug; 32():62-73. PubMed ID: 28687194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of cancers comes of age.
    Yousefi H; Yuan J; Keshavarz-Fathi M; Murphy JF; Rezaei N
    Expert Rev Clin Immunol; 2017 Oct; 13(10):1001-1015. PubMed ID: 28795649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.